Invention Grant
- Patent Title: Quinazoline compound for EGFR inhibition
-
Application No.: US16474999Application Date: 2017-12-29
-
Publication No.: US11040984B2Publication Date: 2021-06-22
- Inventor: Xile Liu , Charles Z. Ding , Shuhui Chen , Lingyun Wu , Lihong Hu , Haiwen Wan
- Applicant: MEDSHINE DISCOVERY INC.
- Applicant Address: CN Jiangsu
- Assignee: MEDSHINE DISCOVERY INC.
- Current Assignee: MEDSHINE DISCOVERY INC.
- Current Assignee Address: CN Jiangsu
- Agency: Novick, Kim & Lee, PLLC
- Agent Allen Xue
- Priority: CN201611259071.9 20161230
- International Application: PCT/CN2017/119993 WO 20171229
- International Announcement: WO2018/121758 WO 20180705
- Main IPC: C07D498/04
- IPC: C07D498/04 ; A61P35/00 ; C07D403/14 ; C07D413/10 ; C07D498/10 ; A61K45/06
Abstract:
Disclosed is a novel quinazoline compound. Specifically, disclosed are a compound represented by the formula (I) and a pharmacologically acceptable salt.
Information query
